Bavarian Nordic have just failed to take their Prostavac to stage 3.
this haven't ben a nice day for the Danish company. they lost 6 billion danish krones ( 1 Billion $ )
there have been high hopes for the company on this product and expectations have been very high and have driven the price high.
but meanwhile people have been observing the process for the Prostavac, they have been making other products where a successful negotiation with the American market can secure them profit for the next future.
A big win will be if the drug will be accepted as a combination drug.
The price is very close to the previously gab between 147-166. the price have a chance to close it before moving up again.
i will therefore Long until it will hit the resistance at 264-265.
and short from the resistance to 147-166
Lets see how it goes. many they will surprise and their product will be accepted as a combination drug. this can drive the price back to its original level.
this haven't ben a nice day for the Danish company. they lost 6 billion danish krones ( 1 Billion $ )
there have been high hopes for the company on this product and expectations have been very high and have driven the price high.
but meanwhile people have been observing the process for the Prostavac, they have been making other products where a successful negotiation with the American market can secure them profit for the next future.
A big win will be if the drug will be accepted as a combination drug.
The price is very close to the previously gab between 147-166. the price have a chance to close it before moving up again.
i will therefore Long until it will hit the resistance at 264-265.
and short from the resistance to 147-166
Lets see how it goes. many they will surprise and their product will be accepted as a combination drug. this can drive the price back to its original level.